Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federica Cattani

Showing results (111-120 of 129) with videos related to

Pageof 13
Sort By:
Clinical Genitourinary Cancer|February 11, 2017
Salvage Stereotactic Body Radiotherapy for Isolated Lymph Node Recurrent Prostate Cancer: Single Institution Series of 94 Consecutive Patients and 124 Lymph NodesBarbara Alicja Jereczek-Fossa, Giuseppe Fanetti, Cristiana Fodor, et al.
BMC Cancer|April 3, 2022
Single fraction ablative preoperative radiation treatment for early-stage breast cancer: the CRYSTAL study - a phase I/II clinical trial protocolMaria Alessia Zerella, Mattia Zaffaroni, Giuseppe Ronci, et al.
Tumori|December 24, 2016
Phase II multi-institutional clinical trial on a new mixed beam RT scheme of IMRT on pelvis combined with a carbon ion boost for high-risk prostate cancer patientsGiulia Marvaso, Barbara A Jereczek-Fossa, Barbara Vischioni, et al.
Insights Into Imaging|August 17, 2022
Quality assurance for automatically generated contours with additional deep learningLars Johannes Isaksson, Paul Summers, Abhir Bhalerao, et al.
BMC Cancer|December 15, 2023
Multi-omics integrative modelling for stereotactic body radiotherapy in early-stage non-small cell lung cancer: clinical trial protocol of the MONDRIAN studyStefania Volpe, Mattia Zaffaroni, Gaia Piperno, et al.
Tumori|August 13, 2016
Rationale and protocol of AIRC IG-13218, short-term radiotherapy for early prostate cancer with concomitant boost to the dominant lesionGiorgia Timon, Delia Ciardo, Alessia Bazani, et al.
Frontiers in Oncology|December 6, 2021
Mixed-Beam Approach for High-Risk Prostate Cancer Carbon-Ion Boost Followed by Photon Intensity-Modulated Radiotherapy: Preliminary Results of Phase II Trial AIRC-IG-14300Giulia Marvaso, Barbara Vischioni, Matteo Pepa, et al.
The Lancet. Oncology|March 6, 2025
ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-label, phase 2 clinical trialGiulia Marvaso, Giulia Corrao, Mattia Zaffaroni, et al.
Cancers|July 2, 2021
Exploring miRNA Signature and Other Potential Biomarkers for Oligometastatic Prostate Cancer Characterization: The Biological Challenge behind Clinical Practice. A Narrative ReviewGiulia Corrao, Mattia Zaffaroni, Luca Bergamaschi, et al.
Tumori|February 8, 2013
Second malignancies following breast cancer treatment: a case-control study based on the Peridose methodology. Allegro project (task 5.4)Roberto Orecchia, Barbara A Jereczek-Fossa, Elena Rondi, et al.
Pageof 13

Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
Clinical Genitourinary Cancer|February 11, 2017
Salvage Stereotactic Body Radiotherapy for Isolated Lymph Node Recurrent Prostate Cancer: Single Institution Series of 94 Consecutive Patients and 124 Lymph NodesBarbara Alicja Jereczek-Fossa, Giuseppe Fanetti, Cristiana Fodor, et al.
BMC Cancer|April 3, 2022
Single fraction ablative preoperative radiation treatment for early-stage breast cancer: the CRYSTAL study - a phase I/II clinical trial protocolMaria Alessia Zerella, Mattia Zaffaroni, Giuseppe Ronci, et al.
Tumori|December 24, 2016
Phase II multi-institutional clinical trial on a new mixed beam RT scheme of IMRT on pelvis combined with a carbon ion boost for high-risk prostate cancer patientsGiulia Marvaso, Barbara A Jereczek-Fossa, Barbara Vischioni, et al.
Insights Into Imaging|August 17, 2022
Quality assurance for automatically generated contours with additional deep learningLars Johannes Isaksson, Paul Summers, Abhir Bhalerao, et al.
BMC Cancer|December 15, 2023
Multi-omics integrative modelling for stereotactic body radiotherapy in early-stage non-small cell lung cancer: clinical trial protocol of the MONDRIAN studyStefania Volpe, Mattia Zaffaroni, Gaia Piperno, et al.
Tumori|August 13, 2016
Rationale and protocol of AIRC IG-13218, short-term radiotherapy for early prostate cancer with concomitant boost to the dominant lesionGiorgia Timon, Delia Ciardo, Alessia Bazani, et al.
Frontiers in Oncology|December 6, 2021
Mixed-Beam Approach for High-Risk Prostate Cancer Carbon-Ion Boost Followed by Photon Intensity-Modulated Radiotherapy: Preliminary Results of Phase II Trial AIRC-IG-14300Giulia Marvaso, Barbara Vischioni, Matteo Pepa, et al.
The Lancet. Oncology|March 6, 2025
ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-label, phase 2 clinical trialGiulia Marvaso, Giulia Corrao, Mattia Zaffaroni, et al.
Cancers|July 2, 2021
Exploring miRNA Signature and Other Potential Biomarkers for Oligometastatic Prostate Cancer Characterization: The Biological Challenge behind Clinical Practice. A Narrative ReviewGiulia Corrao, Mattia Zaffaroni, Luca Bergamaschi, et al.
Tumori|February 8, 2013
Second malignancies following breast cancer treatment: a case-control study based on the Peridose methodology. Allegro project (task 5.4)Roberto Orecchia, Barbara A Jereczek-Fossa, Elena Rondi, et al.
Pageof 13